What Vnzymes does

Vnzymes, operating under the legal entity Victory Enzymes GmbH, is a German biotechnology company that develops and commercializes enzyme preparations and plant-based feed additives for the animal nutrition and health sector. Its portfolio comprises three flagship products: Winzyme X, a patented xylanase that hydrolyzes arabinoxylan-polysaccharides in cereals to release xylo-oligosaccharides and ferulic acid; Winzyme PhytaPro, a 4th-generation phytase engineered via DNA shuffling, directed evolution, molecular dynamics, and high-throughput screening with documented thermal stability (>85% activity after 85°C exposure) and pH adaptability from 2 to 9; and the Maclamax Series, micro-pelleted plant extracts derived from Macleaya cordata for gut health, anti-inflammation, and immune support in livestock. Target species include poultry, swine, ruminants, and aquaculture, with customers being feed manufacturers, integrators, and livestock producers seeking improved feed conversion, phosphorus bioavailability, and reduced reliance on inorganic phosphate and antibiotics.

Vnzymes is the European subsidiary and flagship brand of Chinese parent VTR Biotech Group, which has 30+ years of bioscience experience and a sales network spanning more than 60 countries. The European business is structured around a Frankfurt am Main headquarters (opened November 2025) supporting R&D and technical services, with a registered office in Bad Homburg. Go-to-market is asset-light and channel-led: exclusive distribution rights have been granted to NAGEL Feed Ingredients GmbH (effective March 2025) for 13 European markets including Germany, the Nordics, the UK, Poland, the Czech Republic, and several CEE countries, and to Innovabiotics S.L. (March 2026) for Spain, Italy, and Portugal. Revenue is generated through one-time product sales of solid and liquid enzyme preparations and plant extract granules, supplemented by technical services and application support, with quote-based, individually contracted pricing and no publicly disclosed price list.

As of March 2026, the company's European regulatory position is anchored by EU Commission authorization for Winzyme PhytaPro under Regulation (EC) No 1831/2003 with EFSA evaluation, providing credibility in Europe's stringent feed additive regime. Marketing efforts combine a multilingual corporate website (English, German, Spanish, French), an email newsletter program, and active participation in major industry events such as EuroTier 2024 in Hannover. Leadership consists of CEO Cindy Chen and Senior Technical Director Dr. Wang Yufeng, with a headcount of 1-10 employees.

Name

Vnzymes

Legal name

Victory Enzymes GmbH

Website

https://vnzymes.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

1–10 employees

Short description

Vnzymes is a German biotechnology company and European subsidiary of China's VTR Biotech Group that develops and sells feed enzymes (xylanase, phytase) and Macleaya cordata plant extracts for livestock producers, feed manufacturers, and integrators across Europe via exclusive distribution partners.

Ownership category

akta.pro rank

Product category

Animal Feed Additives

NAICS

Other Animal Food Manufacturing (311119), Animal Food Manufacturing (31111)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Enzymes (Phytase, Xylanase, Protease) (AFADALAD)

akta.pro secondary industry

Non-Antibiotic Health & Performance Supplements (Immune, Gut Health, Stress/Heat Support) (AFADALAO)

Keywords

• Feed enzymes
• Animal nutrition
• Phytase supplements
• Xylanase enzymes
• Plant extract additives

Headquarters

HQ city

Bad Homburg

HQ country

Germany

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Feed Enzyme Products: Sale of proprietary enzyme preparations including xylanase (Winzyme X) and phytase (Winzyme PhytaPro) for animal feed applications, available in solid and liquid forms for poultry, swine, aquaculture, and ruminants.
2. Plant Extract Products: Sale of Maclamax series derived from Macleaya cordata plant extracts, distributed in granule/micro-pelleted form as natural feed additives for animal nutrition.
3. Technical Services & Application Support: Technical development and technical service support in the field of enzyme preparations, including formulation optimization and application troubleshooting for customers.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Vnzymes develops and commercializes proprietary enzyme preparations (xylanase and phytase) and plant-extract feed additives for the animal nutrition and health sector. Its three flagship products — Winzyme X (xylanase), Winzyme PhytaPro (phytase), and the Maclamax Series (Macleaya cordata plant extract) — are sold to feed manufacturers, animal nutrition companies, and livestock producers in Europe to improve feed efficiency, phosphorus bioavailability, gut health, and animal growth performance.

Product overview

Vnzymes is a German biotechnology company and European subsidiary of VTR Biotech Group that develops and commercializes biosolutions for animal nutrition and health. The company's product portfolio consists of three main offerings: Winzyme® X (a patented xylanase enzyme that breaks down arabinoxylans to improve feed efficiency and intestinal health), Winzyme® PhytaPro (a 4th generation phytase enzyme that enhances phosphorus bioavailability from phytate), and Maclamax® Series (a plant extract derived from Macleaya cordata for gut health and immune support). All products are available in solid and liquid/micro-pelleted forms and target livestock including poultry, swine, ruminants, and aquaculture.

Differentiator

Problem solved

Functional benefit

Products and services

• Winzyme X Xylanase Patented xylanase preparation with high enzyme activity that targets enzymatic hydrolysis of arabinoxylan-polysaccharides in cereals, producing xylo-oligosaccharides and ferulic acid to enhance intestinal health, antioxidant capacity, feed efficiency, and protein availability in animals. Available in solid and liquid forms for poultry, swine, and ruminants.
• Winzyme PhytaPro Phytase A premium 4th-generation phytase solution developed using advanced bioinformatics, DNA shuffling, directed evolution, high-throughput screening, and liquid fermentation. Offers high catalytic efficiency, thermal stability (over 85% activity retention after 85°C for 5 minutes; 82%-98% after feed conditioning and pelleting), acid resistance, and pH adaptability from pH 2 to 9. Enhances phosphorus bioavailability from phytate, reducing the need for inorganic phosphate supplementation. Available in solid and liquid forms for poultry, swine, aquaculture, and ruminants.
• Maclamax Series (Macleaya cordata) Plant-based solutions derived from Macleaya cordata (Macleaya Cordata Leaf) in micro-pelleted granule form. Supports gut health, reduces inflammation, enhances nutrient absorption, and improves immune function and growth rates in livestock. Natural feed additive positioned as an antibiotic-reduction and gut health solution.
• Technical Services and Application Support Technical development and application support services in the field of enzyme preparations, including formulation optimization and application troubleshooting for feed manufacturer customers.

Quantifiable outcome

• Winzyme PhytaPro retains over 85% of enzyme activity after 85°C for 5 minutes; 82%-98% retention after feed conditioning and pelleting
• +2 more outcomes

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• Innovabiotics S.L.coreChannel Partner/ Reseller/ Distributor · 5 March 2026Distribution agreement appointed Innovabiotics as authorized distributor for Spain, Italy, and Portugal, representing Vnzymes' portfolio of Macleaya cordata products and enzyme solutions for animal nutrition and industrial applications. Signed at VTR Biotech headquarters in Zhuhai, China. The partnership aims to accelerate adoption of advanced enzyme and phytogenic solutions across Southern Europe's dynamic agricultural region.
• NAGEL Feed Ingredients GmbH (NFI)coreChannel Partner/ Reseller/ Distributor · 19 February 2025Exclusive distribution agreement effective March 2025 grants NFI exclusive rights to distribute all three flagship feed enzyme products of Vnzymes across 13 European markets: Germany, Denmark, Netherlands, Poland, UK, Czech Republic, Greece, Romania, Hungary, Croatia, Finland, Slovakia, and Bulgaria. NFI will work closely with Vnzymes technical and sales teams to offer tailored solutions. The partnership is built on shared values of sustainability, innovation, and customer satisfaction.
• VTR Biotech GroupcoreOthersVnzymes is the new brand and European subsidiary of VTR Biotech Group. Founded on the strong foundation of VTR Biotech's global resources and scientific expertise, Vnzymes delivers biosolutions promoting sustainability, efficiency, and responsibility. VTR Biotech has dedicated more than 30 years to the mission of 'Bioscience Impact Tomorrow' and has established a global sales network across more than 60 countries and regions. Vnzymes serves as the flagship brand of VTR Biotech.

Scale indicators3 records

Recent moves7 records

Expansion highlights4 records

Emerging players

• BioResource International: Specialty animal nutrition company developing enzyme-based feed additives including xylanase products. Smaller specialty comparable with focused enzyme technology similar in positioning to Vnzymes.

Broad incumbents

• Novonesis (formerly Novozymes): Global enzyme market leader with a dedicated feed enzyme portfolio including phytase and xylanase products. Most direct large-scale comparable in feed enzyme biotechnology, with significantly greater R&D scale and direct global distribution.
• IFF (Danisco Animal Nutrition): Major animal nutrition player offering feed enzymes including Axtra phytase and xylanase. Direct overlap with Vnzymes' enzyme portfolio, with broader portfolio and global reach.
• Phibro Animal Health: Animal health and nutrition company offering nutritional specialty products and feed additives for livestock producers. Competes in similar feed additive categories with greater scale and direct salesforce.
• DSM-Firmenich (Animal Nutrition & Health): Global animal nutrition and health giant offering feed enzymes, vitamins, and gut health solutions. Overlaps with Vnzymes' phytase/xylanase and gut health categories, with much larger scale and direct technical service.
• Elanco Animal Health: Large animal health company with feed additive and nutritional health products for livestock. Adjacent competitor in animal nutrition and gut health with broader pharmaceutical portfolio.
• BASF Animal Nutrition: Global chemicals and nutrition player with animal nutrition feed additives including enzymes. Competes in the same feed enzyme and gut health categories with substantially greater resources and reach.

Direct peers

• AB Vista: Subsidiary of AB Agri specializing in feed enzymes and gut health products for livestock, including phytase products. Direct competitor in the European feed enzyme market with overlapping product categories.
• Adisseo: Specialist feed additive company offering enzymes, vitamins, and gut health products for animal nutrition. Direct comparable in feed enzyme category with strong European presence and similar product positioning.
• Kemin Industries: Specialty ingredient manufacturer with animal nutrition portfolio including gut health solutions, enzymes, and plant-based additives. Comparable scope across Vnzymes' enzyme and phytogenic product lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/vnzymes

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vnzymes